Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

449
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
449
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

608
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
608
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

619
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
619
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

293
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
293
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

456
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
456
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

460
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New treatment options for generalized HER2-positive breast cancer in higher-line systemic palliative therapy.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Prophylactic surgical mesh placement as a prevention of parastomal hernia in open radical cystectomy with ileal conduit diversion - pilot study.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2024
Same author

Native nephrectomy in patients with autosomal dominant polycystic kidney disease in the kidney transplant program - single-center retrospective results of 2000-2020.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2023
Same author

Fecal microbiota transplantation - new possibility to influence the results of therapy of cancer patients.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2022
Same author

Can the prophylactic administration of tranexamic acid reduce the blood loss after robotic-assisted radical prostatectomy? Robotic Assisted Radical Prostatectomy with tranEXamic acid (RARPEX): study protocol for a randomized controlled trial.

Trials·2022
Same author

Future of lung cancer treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2021

Related Experiment Video

Updated: Jan 25, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

20.0K

Urinary Tract and Gynecologic Malignancies.

J Špaček, J Petera, M Broďák

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |May 1, 2019
    PubMed
    Summary

    Gynecologic cancer treatments, including surgery and radiotherapy, can cause urological side effects. Understanding and preventing these complications is crucial for maintaining patients' quality of life.

    Keywords:
    gynecologic neoplasms - complication - urinary tract - quality of life This work was supported by project PROGES Q40. The authors declare they have no potential conflicts of interest concerning drugsor services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers. Submitted: 27. 9. 2018 Accepted: 21. 10. 2018products

    More Related Videos

    Transurethral Induction of Mouse Urinary Tract Infection
    09:24

    Transurethral Induction of Mouse Urinary Tract Infection

    Published on: August 5, 2010

    37.4K
    An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
    07:57

    An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

    Published on: June 24, 2025

    1.1K

    Related Experiment Videos

    Last Updated: Jan 25, 2026

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
    05:25

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

    Published on: August 14, 2019

    20.0K
    Transurethral Induction of Mouse Urinary Tract Infection
    09:24

    Transurethral Induction of Mouse Urinary Tract Infection

    Published on: August 5, 2010

    37.4K
    An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
    07:57

    An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

    Published on: June 24, 2025

    1.1K

    Area of Science:

    • Oncology
    • Urology
    • Gynecology

    Background:

    • The anatomical proximity of the urogenital system presents challenges in gynecologic oncology.
    • Treatment-associated toxicity, particularly urological adverse effects, impacts patient quality of life.
    • Despite advancements, treatment-related complications in gynecologic cancer persist and are increasing.

    Purpose of the Study:

    • To review treatment modalities for gynecologic cancer.
    • To discuss common urological adverse effects of these treatments.
    • To emphasize the importance of side effect prevention for preserving quality of life.

    Main Methods:

    • Literature review of gynecologic cancer treatment modalities.
    • Analysis of common urological complications associated with oncologic therapies.
    • Discussion of prevention strategies for treatment-related adverse effects.

    Main Results:

    • Radical surgery and oncological therapies require careful planning to preserve non-gynecological structures.
    • Combination therapies, especially surgery and radiotherapy, pose challenges.
    • Urological adverse effects are a significant concern impacting quality of life.

    Conclusions:

    • Multidisciplinary team cooperation is essential for gynecologic cancer treatment.
    • Management of urological adverse effects depends on patient prognosis and future oncologic plans.
    • Preventing and managing urological complications is key to improving outcomes and quality of life.